Buybacks Archives - Page 18 of 84

2 minute read

Harmony Biosciences Sees 2024 Net Product Revenue Projected Between $700M-$720M; $50M Common Stock Repurchase In Q4 Bringing 2023 Total To $100M; Expect To Continue Opportunistic Share Repurchases In 2024

January 8, 9:34 AM

2024 Key PrioritiesContinued Strong Growth for WAKIX in Adult Narcolepsy Drive commercial strategy to achieve Net Revenue >$700 million

HRMY

2 minute read

Corcept Therapeutics Provides Financial Update And Announces $200M Stock Repurchase Program; Sees Q4 Revenue $135.4M Vs $127.85M Est.; FY23 Revenue $482.4M Vs $474.82M Est.; FY24 Revenue $600M–$630M Vs $513.85M Est.

By Benzinga Newsdesk

January 8, 9:28 AM

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating

CORT

2 minute read

Exelixis Announces The Board Of Directors Has Authorized A $450M Share Repurchase In 2024 After Successful Completion Of $550M Share Repurchase In 2023

By Benzinga Newsdesk

January 7, 6:30 PM

Preliminary Fiscal Year 2023 Financial Results & 2024 Financial GuidanceExelixis is providing the following preliminary unaudited 2023 financial results and financial guidance for 2024: Fiscal Year 2023Fiscal

EXEL

1 minute read

QIAGEN To Return ~$300M To Shareholders Through A Synthetic Share Repurchase

By Charles Gross

January 7, 3:36 PM

QIAGEN N.V. announces a plan to return up to approximately $300 million (maximum EUR 273 million) to shareholders through a synthetic share repurchase that combines a direct capital repayment with a reverse stock

QGEN

1 minute read

Dave Announces Repurchase Of $100M Convertible Note from FTX Ventures Ltd For A Discounted Purchase Price Of $71M

By Benzinga Newsdesk

January 5, 10:01 AM

Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced it has reached an agreement with FTX Ventures Ltd. ("FTX") to purchase a convertible promissory note that it

DAVE

2 minute read

Why Paint & Coating Manufacturing Company RPM’s Shares Are Sliding Today

By Lekha Gupta

January 4, 12:29 PM

RPM International Inc (NYSE: RPM) shares are trading lower after the company reported

RPM

3 minute read

Sprinklr Appoints Trac Pham New Interim Chief Operating Officer, Authorizes $100M Stock Buyback Program, And Reaffirms Financial Guidance For Q4 And FY24

By Benzinga Newsdesk

January 4, 9:22 AM

Mr. Pham will work cross-functionally on orchestrating Sprinklr's operating rhythm and lead planning efforts with a focus on continuing to improve go-to-market strategy.As the company actively seeks a permanent President

CXM

1 minute read

Why Collegium Pharmaceutical Shares Are Gaining Today

By Akanksha Bakshi

January 3, 12:39 PM

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial

COLL

2 minute read

What’s Going On With Alibaba Stock Wednesday?

By Anusuya Lahiri

January 3, 8:20 AM

Alibaba Group Holding Limited (NYSE: BABA) stock declined, contributing to a broader drop in Hong Kong stocks to a nearly two-week low. Concerns about China's economic growth and diminishing hopes for immediate U.S. interest rate cuts have affected market sentiments.

AMZN